{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:05:31Z","timestamp":1789873531227,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Projects in Guangzhou","award":["No.202201020529"],"award-info":[{"award-number":["No.202201020529"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["No. B2021267"],"award-info":[{"award-number":["No. B2021267"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The association between non-alcoholic fatty liver disease (NAFLD) and osteoarthritis (OA) has not been well elucidated. The aim of the present study was to investigate the association between NAFLD and OA in the US adults.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was performed on participants in the 2017\u20132018 National Health and Nutrition Examination Survey (NHANES) cycle. NAFLD was defined by the vibration-controlled transient elastography. The diagnosis of OA was based on self-reported data. Weighted multiple logistic regression models and stratified analyses were performed to explore the relationship and verify the stability of the conclusions. Sensitivity analysis using multiple imputation for missing data and propensity score matching (PSM) were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 2622 participants [Male: 1260 (47.8%)] were included in this study with a mean age of 48.1\u00a0years old (95% CI, 46.6\u201349.6\u00a0years old), containing 317 (12.8%) OA patients and 1140 NAFLD patients (41.5%). A logistic regression indicated a significant association between NAFLD and OA without adjustment [odds ratio (OR)\u2009=\u20092.05; 95% CI, 1.52\u20132.78]. The association remained stable after adjustment for covariates (OR\u2009=\u20091.72; 95% CI, 1.26\u20132.34). Sensitivity analysis of missing data with multiple interpolation and PSM found similar results. A significant and consistent association of NAFLD with OA was still observed in each subgroup stratified by age and metabolic syndrome (MetS). Stratified by sex, obesity, and sensitivity c-reactive protein (hs-CRP) category, a statistically significant association was only shown in females, those without obesity, and those without hyper hs-CRP. The results illustrated that the relationship between NAFLD and OA was stable in all subgroups and had no interaction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>NAFLD was positively correlated with OA. Given the current pandemic of NAFLD and OA, clinicians should screen for NAFLD in arthritis patients and intervene early.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-024-03272-2","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T06:02:29Z","timestamp":1706680949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Association of non-alcoholic fatty liver disease with self-reported osteoarthritis among the US adults"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"issue":"7","key":"3272_CR1","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/art.42089","volume":"74","author":"H Long","year":"2022","unstructured":"Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, Lin J, Guo A. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022;74(7):1172\u201383.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"3272_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580\u201392.","journal-title":"Nat Rev Rheumatol"},{"key":"3272_CR3","doi-asserted-by":"publisher","first-page":"907750","DOI":"10.3389\/fimmu.2022.907750","volume":"13","author":"U Nedunchezhiyan","year":"2022","unstructured":"Nedunchezhiyan U, Varughese I, Sun AR, Wu X, Crawford R, Prasadam I. Obesity, inflammation, and immune system in osteoarthritis. Front Immunol. 2022;13:907750.","journal-title":"Front Immunol"},{"issue":"1","key":"3272_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13075-019-2081-x","volume":"21","author":"BM Dickson","year":"2019","unstructured":"Dickson BM, Roelofs AJ, Rochford JJ, Wilson HM, De Bari C. The burden of metabolic syndrome on osteoarthritic joints. Arthritis Res Ther. 2019;21(1):289.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3272_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.semarthrit.2019.01.005","volume":"49","author":"N Veronese","year":"2019","unstructured":"Veronese N, Cooper C, Reginster JY, Hochberg M, Branco J, Bruy\u00e8re O, Chapurlat R, Al-Daghri N, Dennison E, Herrero-Beaumont G, et al. Type 2 diabetes mellitus and osteoarthritis. Semin Arthritis Rheum. 2019;49(1):9\u201319.","journal-title":"Semin Arthritis Rheum"},{"key":"3272_CR6","doi-asserted-by":"crossref","unstructured":"Englund M. Osteoarthritis, part of life or a curable disease? A bird's-eye view. J Intern Med. 2023;293(6):681\u201393.","DOI":"10.1111\/joim.13634"},{"issue":"4","key":"3272_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465\u201374.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"3272_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","volume":"104","author":"B Abramoff","year":"2020","unstructured":"Abramoff B, Caldera FE. Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Med Clin North Am. 2020;104(2):293\u2013311.","journal-title":"Med Clin North Am"},{"issue":"7","key":"3272_CR9","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592\u2013609.","journal-title":"Gastroenterology"},{"issue":"9","key":"3272_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"3272_CR11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.28785","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577\u201386.","journal-title":"Hepatology"},{"issue":"1","key":"3272_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","volume":"18","author":"S Francque","year":"2021","unstructured":"Francque S, Szabo G, Abdelmalek MF, Byrne CD, Cusi K, Dufour JF, Roden M, Sacks F, Tacke F. Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. Nat Rev Gastroenterol Hepatol. 2021;18(1):24\u201339.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"3272_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274\u201385.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"3272_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tem.2021.04.008","volume":"32","author":"S Lim","year":"2021","unstructured":"Lim S, Kim JW, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab. 2021;32(7):500\u201314.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"3272_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10787-021-00842-7","volume":"29","author":"AL Han","year":"2021","unstructured":"Han AL. Association between metabolic associated fatty liver disease and osteoarthritis using data from the Korean national health and nutrition examination survey (KNHANES). Inflammopharmacology. 2021;29(4):1111\u20138.","journal-title":"Inflammopharmacology"},{"issue":"5","key":"3272_CR16","doi-asserted-by":"publisher","first-page":"100322","DOI":"10.1016\/j.jhepr.2021.100322","volume":"3","author":"SM Francque","year":"2021","unstructured":"Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Fr\u00fchbeck G, et al. Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep. 2021;3(5):100322.","journal-title":"JHEP Rep"},{"key":"3272_CR17","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u2013402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"issue":"5","key":"3272_CR18","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156(5):1264\u20131281.e1264.","journal-title":"Gastroenterology"},{"issue":"6","key":"3272_CR19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, et al. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"6","key":"3272_CR20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/ije\/dyy187","volume":"47","author":"A Mendy","year":"2018","unstructured":"Mendy A, Park J, Vieira ER. Osteoarthritis and risk of mortality in the USA: a population-based cohort study. Int J Epidemiol. 2018;47(6):1821\u20139.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"3272_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/joca.1997.0098","volume":"6","author":"LM March","year":"1998","unstructured":"March LM, Schwarz JM, Carfrae BH, Bagge E. Clinical validation of self-reported osteoarthritis. Osteoarthritis Cartilage. 1998;6(2):87\u201393.","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"3272_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamainternmed.2019.6980","volume":"180","author":"Z Shan","year":"2020","unstructured":"Shan Z, Guo Y, Hu FB, Liu L, Qi Q. Association of Low-Carbohydrate and Low-Fat Diets With Mortality Among US Adults. JAMA Intern Med. 2020;180(4):513\u201323.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"3272_CR23","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999\u20132014.e1991.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"3272_CR24","first-page":"S14","volume":"43","author":"Classification and Diagnosis of Diabetes","year":"2020","unstructured":"Classification and Diagnosis of Diabetes. Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14\u2013s31.","journal-title":"Diabetes Care"},{"issue":"12","key":"3272_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","volume":"324","author":"P Muntner","year":"2020","unstructured":"Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, Colantonio LD. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999\u20132000 to 2017\u20132018. JAMA. 2020;324(12):1190\u2013200.","journal-title":"JAMA"},{"issue":"17","key":"3272_CR26","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735\u201352.","journal-title":"Circulation"},{"issue":"6","key":"3272_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/hep4.1689","volume":"5","author":"AS Barritt","year":"2021","unstructured":"Barritt AS, Watkins S, Gitlin N, Klein S, Lok AS, Loomba R, Schoen C, Reddy KR, Trinh HN, Mospan AR, et al. Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study. Hepatol Commun. 2021;5(6):938\u201346.","journal-title":"Hepatol Commun"},{"issue":"2","key":"3272_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/ard.2006.053538","volume":"66","author":"M Reijman","year":"2007","unstructured":"Reijman M, Pols HA, Bergink AP, Hazes JM, Belo JN, Lievense AM, Bierma-Zeinstra SM. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis. 2007;66(2):158\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3272_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","volume":"21","author":"F Berenbaum","year":"2013","unstructured":"Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16\u201321.","journal-title":"Osteoarthritis Cartilage"},{"issue":"10","key":"3272_CR30","doi-asserted-by":"publisher","first-page":"e13490","DOI":"10.1111\/obr.13490","volume":"23","author":"Y Cai","year":"2022","unstructured":"Cai Y, Chen X, Yi B, Li J, Wen Z. Pathophysiology roles for adenosine 2A receptor in obesity and related diseases. Obes Rev. 2022;23(10):e13490.","journal-title":"Obes Rev"},{"issue":"1","key":"3272_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.29777","volume":"68","author":"Y Cai","year":"2018","unstructured":"Cai Y, Li H, Liu M, Pei Y, Zheng J, Zhou J, Luo X, Huang W, Ma L, Yang Q, et al. Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity. Hepatology. 2018;68(1):48\u201361.","journal-title":"Hepatology"},{"issue":"12","key":"3272_CR32","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.metabol.2015.08.013","volume":"64","author":"YN Dai","year":"2015","unstructured":"Dai YN, Zhu JZ, Fang ZY, Zhao DJ, Wan XY, Zhu HT, Yu CH, Li YM. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Metabolism. 2015;64(12):1667\u201373.","journal-title":"Metabolism"},{"issue":"12","key":"3272_CR33","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1172\/JCI96324","volume":"127","author":"L Guo","year":"2017","unstructured":"Guo L, Zhang P, Chen Z, Xia H, Li S, Zhang Y, Kobberup S, Zou W, Lin JD. Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression. J Clin Invest. 2017;127(12):4449\u201361.","journal-title":"J Clin Invest"},{"issue":"1","key":"3272_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00223-021-00897-2","volume":"110","author":"L Shi","year":"2022","unstructured":"Shi L, Xu X, Meng B, He K, Sun Y, Tong J, Xu J, Cheng Y, Gan G, Xiang G. Neuregulin 4 Attenuates Osteoarthritis Progression by Inhibiting Inflammation and Apoptosis of Chondrocytes in Mice. Calcif Tissue Int. 2022;110(1):131\u201342.","journal-title":"Calcif Tissue Int"},{"key":"3272_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.977625","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Zhang Y, Luo H, Lin R. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Front Endocrinol (Lausanne). 2022;13: 977625.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"3272_CR36","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/art.39561","volume":"68","author":"D Hamada","year":"2016","unstructured":"Hamada D, Maynard R, Schott E, Drinkwater CJ, Ketz JP, Kates SL, Jonason JH, Hilton MJ, Zuscik MJ, Mooney RA. Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus. Arthritis Rheumatol. 2016;68(6):1392\u2013402.","journal-title":"Arthritis Rheumatol"},{"key":"3272_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/CLEP.S145823","volume":"10","author":"AI Hellevik","year":"2018","unstructured":"Hellevik AI, Johnsen MB, Langhammer A, Baste V, Furnes O, Storheim K, Zwart JA, Flugsrud GB, Nordsletten L. Metabolic syndrome as a risk factor for total hip or knee replacement due to primary osteoarthritis: a prospective cohort study (the HUNT study and the Norwegian Arthroplasty Register). Clin Epidemiol. 2018;10:83\u201396.","journal-title":"Clin Epidemiol"},{"issue":"4","key":"3272_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00011-020-01326-0","volume":"69","author":"M Scotece","year":"2020","unstructured":"Scotece M, Koskinen-Kolasa A, Pemmari A, Lepp\u00e4nen T, H\u00e4m\u00e4l\u00e4inen M, Moilanen T, Moilanen E, Vuolteenaho K. Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients. Inflamm Res. 2020;69(4):415\u201321.","journal-title":"Inflamm Res"},{"key":"3272_CR39","doi-asserted-by":"publisher","first-page":"3105248","DOI":"10.1155\/2020\/3105248","volume":"2020","author":"J Xiong","year":"2020","unstructured":"Xiong J, Long J, Chen X, Li Y, Song H. Dyslipidemia Might Be Associated with an Increased Risk of Osteoarthritis. Biomed Res Int. 2020;2020:3105248.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3272_CR40","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jcp.30593","volume":"237","author":"S Zhu","year":"2022","unstructured":"Zhu S, Bennett S, Li Y, Liu M, Xu J. The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases. J Cell Physiol. 2022;237(1):480\u20138.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3272_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bcp.2015.08.098","volume":"98","author":"HJ Hwang","year":"2015","unstructured":"Hwang HJ, Jung TW, Kim BH, Hong HC, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH, et al. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. Biochem Pharmacol. 2015;98(1):157\u201366.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"3272_CR42","first-page":"283","volume":"14","author":"Z Wen","year":"2023","unstructured":"Wen Z, Sun Q, Shan Y, Xie W, Ding Y, Wang W, Ye R, Xiao W, Li Y. Endoplasmic Reticulum Stress in Osteoarthritis: A Novel Perspective on the Pathogenesis and Treatment. Aging Dis. 2023;14(2):283\u20136.","journal-title":"Aging Dis"},{"issue":"2","key":"3272_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/hep.32562","volume":"77","author":"A Ajoolabady","year":"2023","unstructured":"Ajoolabady A, Kaplowitz N, Lebeaupin C, Kroemer G, Kaufman RJ, Malhi H, Ren J. Endoplasmic reticulum stress in liver diseases. Hepatology. 2023;77(2):619\u201339.","journal-title":"Hepatology"},{"issue":"1","key":"3272_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jhep.2021.01.042","volume":"75","author":"C Liu","year":"2021","unstructured":"Liu C, Zhou B, Meng M, Zhao W, Wang D, Yuan Y, Zheng Y, Qiu J, Li Y, Li G, et al. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease. J Hepatol. 2021;75(1):150\u201362.","journal-title":"J Hepatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03272-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03272-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03272-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T09:11:37Z","timestamp":1706692297000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03272-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3272"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03272-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}